Operational Update & Appendix 4C
Filed with ASX · · 16 pages · English
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified molecular diagnostics company is pleased to provide its Quarterly Activities Report for the period ending 31 March 2019, together with the attached Appendix 4C. Highlights • Memorandum of Understanding signed with TGen Arizona – work underway on specific cooperation Agreements to develop a commercialization stra
Genetic Technologies Limited on 6ix
In the deck
Story so far
Earlier from Genetic Technologies
- TGen MoU Accouncement
- Genetic Technologies Company Profile
- China Announcement
- Investor Presentation 19 March 2019
- ASX Lodgement Supplementary Prospectus
Later from Genetic Technologies
- New Product Announcement
- GTG Announces Offering of American Depositary Shares
- Cleansing Notice
- Genetic Technologies to Appeal Nasdaq Delisting Notice
- Quarterly Update and 4C
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies